The current US Medical Aesthetics Market Size was valued at a significant USD 5.5 billion in 2024, confirming its status as the most substantial and mature medical aesthetics market globally. This high valuation reflects the massive volume of procedures performed annually across the nation, supported by a vast network of specialized practitioners, accredited facilities, and robust consumer marketing efforts by major medical device and pharmaceutical companies.

The projected growth, which will see the US Medical Aesthetics Market Size expand to USD 13.5 billion by 2035, is an indicator of the market's resilience and capacity for continued innovation. This future expansion is dependent on factors such as the continued development of combination therapies (e.g., injectables used with energy devices), the successful marketing to younger consumers focused on prevention, and the introduction of new FDA-cleared aesthetic technologies that push the boundaries of non-surgical results.